Biozone 6™ launches March 15
Biozone 6™ is a new concept for direct single-cell pharmacology from Fluicell that lets users generate dose-response curves or study the effects of multiple drug compounds in an intuitive way, directly on individual cells. With Biozone 6, it will be possible to expose individual cells to up to six different kinds of drugs or six different doses of a single drug in one experiment.
“Biozone 6 corresponds to an expressed need within pharmacological research for versatile high-precisions single-cell technologies that has not been met by other products on the market and that will be of great use for researchers and pharmaceutical companies,” says CEO Victoire Viannay.
Like the rest of Fluicell’s products, Biozone 6 uses Fluicell’s innovative microfluidic single-cell technology. Biozone 6 has been developed in connection with Hoffmann-La Roche to meet the high demands in pharmaceutical research for precision and reliability.
Sign up already today to schedule a demo or to get a quote.